Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation

View ORCID ProfileZhijian Xu, Cheng Peng, Yulong Shi, Zhengdan Zhu, Kaijie Mu, Xiaoyu Wang, View ORCID ProfileWeiliang Zhu
doi: https://doi.org/10.1101/2020.01.27.921627
Zhijian Xu
CAS Key Laboratory of Receptor Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zhijian Xu
  • For correspondence: zjxu@simm.ac.cn wlzhu@simm.ac.cn
Cheng Peng
CAS Key Laboratory of Receptor Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yulong Shi
CAS Key Laboratory of Receptor Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhengdan Zhu
CAS Key Laboratory of Receptor Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaijie Mu
CAS Key Laboratory of Receptor Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaoyu Wang
CAS Key Laboratory of Receptor Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weiliang Zhu
CAS Key Laboratory of Receptor Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Weiliang Zhu
  • For correspondence: zjxu@simm.ac.cn wlzhu@simm.ac.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Article usage

Article usage: January 2020 to March 2023

AbstractFullPdf
Jan 202033041571259
Feb 202049435593052
Mar 202026502571441
May 20201086152617
Jun 2020829113352
Jul 202066392296
Aug 202042051188
Sep 202048431182
Oct 202036826114
Nov 202030028134
Dec 202028946123
Jan 202150724128
Feb 202150825102
Mar 202149721106
Apr 202154840102
May 202145167163
Jun 20214891277
Jul 20214201855
Aug 20212651573
Sep 20212783156
Oct 20212223863
Nov 20211581673
Dec 20211811446
Jan 20221931345
Feb 20221551039
Mar 20221771050
Apr 202216715111
May 20221681858
Jun 20222621143
Jul 2022156332
Aug 2022242238
Sep 20222311748
Oct 2022185828
Nov 2022186852
Dec 20222231450
Jan 20231401445
Feb 20231551444
Mar 2023110016
Back to top
PreviousNext
Posted January 28, 2020.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation
Zhijian Xu, Cheng Peng, Yulong Shi, Zhengdan Zhu, Kaijie Mu, Xiaoyu Wang, Weiliang Zhu
bioRxiv 2020.01.27.921627; doi: https://doi.org/10.1101/2020.01.27.921627
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation
Zhijian Xu, Cheng Peng, Yulong Shi, Zhengdan Zhu, Kaijie Mu, Xiaoyu Wang, Weiliang Zhu
bioRxiv 2020.01.27.921627; doi: https://doi.org/10.1101/2020.01.27.921627

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pharmacology and Toxicology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4229)
  • Biochemistry (9118)
  • Bioengineering (6753)
  • Bioinformatics (23948)
  • Biophysics (12103)
  • Cancer Biology (9498)
  • Cell Biology (13745)
  • Clinical Trials (138)
  • Developmental Biology (7618)
  • Ecology (11664)
  • Epidemiology (2066)
  • Evolutionary Biology (15479)
  • Genetics (10621)
  • Genomics (14298)
  • Immunology (9468)
  • Microbiology (22808)
  • Molecular Biology (9083)
  • Neuroscience (48896)
  • Paleontology (355)
  • Pathology (1479)
  • Pharmacology and Toxicology (2566)
  • Physiology (3826)
  • Plant Biology (8309)
  • Scientific Communication and Education (1467)
  • Synthetic Biology (2294)
  • Systems Biology (6172)
  • Zoology (1297)